🔎 Trials Near Me

Dachaigh › Neuropathaidhean mothachaidh agus fèin-riaghailteach oighreachail › Tennessee › Nashville

Sgrùdaidhean clionaigeach Neuropathaidhean mothachaidh agus fèin-riaghailteach oighreachail ann an Nashville, TN

Tha 6 sgrùdaidhean airson Neuropathaidhean mothachaidh agus fèin-riaghailteach oighreachail a’ lorg phàirtichean aig làraichean ann agus timcheall air Nashville (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Study of ACR-2316 in Specific Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Tennessee Oncology, Franklin · 17 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06667141

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • SCRI Oncology Partners, Nashville
  • Vanderbilt Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT04657068

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Sarah Cannon Research Institute, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT05768139

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

A’ fastadhÌre 1/2
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT07558733

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

A’ fastadhÌre 1
  • Sarah Cannon Cancer Center, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 22 Gibl 2026 · NCT05683418

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

A’ fastadhSgrùdadh amharc
  • Sarah Cannon Research Institute, Nashville
Aoisean 1 gu 100 · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT05868629

Sgrùdaidhean Neuropathaidhean mothachaidh agus fèin-riaghailteach oighreachail ann am bailtean eile

Sgrùdaidhean eile ann an Nashville

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.